Rtw Investments, LP Acadia Pharmaceuticals Inc Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Rtw Investments, LP holds 8,705,501 shares of ACAD stock, worth $128 Million. This represents 2.61% of its overall portfolio holdings.
Number of Shares
8,705,501
Previous 13,707,506
36.49%
Holding current value
$128 Million
Previous $211 Million
24.28%
% of portfolio
2.61%
Previous 3.36%
Shares
9 transactions
Others Institutions Holding ACAD
# of Institutions
328Shares Held
166MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$629 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$204 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$177 Million0.0% of portfolio
-
Morgan Stanley New York, NY7.3MShares$107 Million0.01% of portfolio
-
State Street Corp Boston, MA4.52MShares$66.3 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.37B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...